Latest stories on ASBP
Aspire Biopharma Issues Shareholder Letter | ASBP Stock News
StockTitan50 · neutralgeneral
Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program
Yahoo Top58 · neutralproduct/pr
ASBP news roundup. 3 stories aggregated over the last 30 days. Average 30-day sentiment is 55.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.